BridgeMD
New treatment option for Myotonic Dystrophy Type 1
Official title Pelvic Floor Muscle Training for Women with Myotonic Dystrophy
ClinicalTrials.gov ID: NCT06316778
What this study is testing
- What it's testing
- Myotonic dystrophy type 1 (DM1) is a neuromuscular disease characterized by multisystem manifestations. DM1 can affect the urinary system through the impact of the pelvic floor muscles (PFM).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- confirmed medical diagnosis of myotonic dystrophy type 1 (DM1) with adult phenotype
- symptoms of stress, urge or mixed urinary incontinence
- able to give a free and informed consent
You likely can't join if
- being pregnant, have given birth by vaginal delivery in the last year or plan to become pregnant in the next six months
- present post-void residual urine ≥ 150 ml
- have medical conditions that may have an impact on the symptoms of urinary incontinence and the response to treatments
- present fecal incontinence (≥ 1/week) or significant prolapse (beyond the hymen)
- have already received physiotherapy treatments in pelvic floor rehabilitation or surgery on the perineum
- have a defibrillator, pacemaker or bladder stimulator
The study team makes the final eligibility decision.
Where it's taking place
- Jonquière, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jonquière, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.